Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. IQVIA Holdings Inc.
  6. Summary
    IQV   US46266C1053

IQVIA HOLDINGS INC.

(IQV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/16/2021 06/17/2021 06/18/2021 06/21/2021 06/22/2021 Date
244.23(c) 246.3(c) 239.66(c) 243.45(c) 243.98(c) Last
998 084 1 136 143 4 072 064 1 065 508 1 049 968 Volume
-1.03% +0.85% -2.70% +1.58% +0.22% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 13 426 M - -
Net income 2021 808 M - -
Net Debt 2021 9 900 M - -
P/E ratio 2021 58,7x
Yield 2021 -
Sales 2022 14 545 M - -
Net income 2022 1 021 M - -
Net Debt 2022 9 185 M - -
P/E ratio 2022 45,8x
Yield 2022 -
Capitalization 46 761 M 46 761 M -
EV / Sales 2021 4,22x
EV / Sales 2022 3,85x
Nbr of Employees 72 000
Free-Float 74,2%
More Financials
Company
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions,... 
Read more
More about the company
Ratings of IQVIA Holdings Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about IQVIA HOLDINGS INC.
06/16TEVA PHARMACEUTICAL INDUSTRIES  : Unit Launches Generic Version of Soolantra Cre..
MT
06/14IQVIA  : Subsidiary Expands Laboratory Operations in Scotland
MT
06/14IQVIA  : Q² Solutions Announces Significant Expansion of Laboratory Operations i..
BU
06/11IPSEN  : Finds Potential Treatment Gap Among Spasticity Patients in US
MT
06/08IQVIA  : Q2 Solutions and Tasso Collaborate to Provide Unique Solutions for Pati..
BU
06/04PRESS RELEASE : Novartis announces Tabrecta(R) -2-
DJ
06/03IQVIA  : Global Oncology Innovation Continues Despite Pandemic; Global R&D Pipel..
BU
05/26PRESS RELEASE : Marinomed Biotech AG Reports Financial Results for 1st Quarter 2..
DJ
05/20IQVIA  : CFO, Ron Bruehlman, to Speak at the William Blair Growth Stock Conferen..
BU
05/19IQVIA  : Pharma R&D Activity Surges Even Without COVID-19, Says Report from the ..
BU
05/17PRESS RELEASE : Novartis: US Supreme Court denies Sandoz petition to review bios..
DJ
05/14IQVIA  : KeyBanc Adjusts IQVIA Holdings' Price Target to $260 From $255, Keeps O..
MT
05/13MOVES-Deutsche Bank hires investment banking veteran Priyanka Verma in health..
RE
05/13Top scientists question the need for COVID-19 booster shots
RE
05/12IQVIA  : Argus Adjusts IQVIA Holdings' Price Target to $260 From $220, Keeps Buy..
MT
More news
News in other languages on IQVIA HOLDINGS INC.
06/16KOLINPHARMA  : esclusiva per distribuzione dispositivo medico Dolatrox
05/26DGAP-NEWS : Marinomed Biotech AG berichtet Finanzergebnisse für das 1. Quartal 2..
03/24L'agenda di domani
03/24J&J  : de nouvelles collaborations contre la tuberculose
03/24L'agenda della settimana
More news
Analyst Recommendations on IQVIA HOLDINGS INC.
More recommendations
Chart IQVIA HOLDINGS INC.
Duration : Period :
IQVIA Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 243,98 $
Average target price 256,58 $
Spread / Average Target 5,16%
EPS Revisions
Managers and Directors
NameTitle
Ari Bousbib Chairman, President & Chief Executive Officer
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
W. Richard Staub President-Research & Development Solutions
Kevin C. Knightly President-Technology & Commercial Solutions
Sector and Competitors
1st jan.Capitalization (M$)
IQVIA HOLDINGS INC.36.17%46 761
MODERNA, INC.111.89%83 614
LONZA GROUP AG13.26%52 103
CELLTRION, INC.-24.79%33 793
SEAGEN INC.-9.40%28 728
HANGZHOU TIGERMED CONSULTING CO., LTD14.49%24 977